Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different fentanyl induction doses and fentanyl-induced cough
IRCT20190325043107N70Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of fentanyl in cough (3 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Fentanyl-induced cough incidence and severity. Started Jan 2026; status: completed.
02
Drugs
fentanyl
03
Conditions
cough
Beyond the preview
Go deeper on IRCT20190325043107N70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N70.